Vantage Investment Partners, LLC Zoetis Inc. Transaction History

Vantage Investment Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 25, 2021	SELL	$157.07 - $174.35 $208,588 - $231,536	-1,328 Closed	0 $0
Q3 2020 Oct 22, 2020	BUY	$137.1 - $165.37 $182,068 - $219,611	1,328 New	1,328 $220,000
Q2 2020 Jul 21, 2020	SELL	$111.92 - $142.53 $8.02 Million - $10.2 Million	-71,662 Closed	0 $0
Q1 2020 Apr 28, 2020	BUY	$92.66 - $144.94 $748,692 - $1.17 Million	8,080 Added 12.71%	71,662 $8.43 Million
Q4 2019 Feb 10, 2020	BUY	$116.25 - $133.25 $6,975 - $7,995	60 Added 0.09%	63,582 $8.42 Million
Q3 2019 Oct 24, 2019	SELL	$112.57 - $128.43 $2.62 Million - $2.99 Million	-23,263 Reduced 26.81%	63,522 $7.91 Million
Q2 2019 Aug 07, 2019	BUY	$97.98 - $114.28 $5,682 - $6,628	58 Added 0.07%	86,785 $9.85 Million
Q1 2019 May 10, 2019	BUY	$81.56 - $100.67 $7.07 Million - $8.73 Million	86,727 New	86,727 $8.73 Million

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Vantage Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Vantage Investment Partners, LLC with notifications on news.